316 related articles for article (PubMed ID: 25880178)
1. Six-minute walk test in pulmonary arterial hypertension.
Demir R; Küçükoğlu MS
Anatol J Cardiol; 2015 Mar; 15(3):249-54. PubMed ID: 25880178
[TBL] [Abstract][Full Text] [Related]
2. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
Neal JE; Lee AS; Burger CD
Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
[TBL] [Abstract][Full Text] [Related]
3. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
[TBL] [Abstract][Full Text] [Related]
4. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
5. Six-Minute Walk Test in Evaluation of Children with Pulmonary Arterial Hypertension.
Zuk M; Migdal A; Jagiellowicz-Kowalska D; Mazurkiewicz K; Sadel-Wieczorek A; Brzezinska-Rajszys G
Pediatr Cardiol; 2017 Apr; 38(4):754-761. PubMed ID: 28239753
[TBL] [Abstract][Full Text] [Related]
6. The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension.
Gaine S; Simonneau G
Eur Respir Rev; 2013 Dec; 22(130):487-94. PubMed ID: 24293464
[TBL] [Abstract][Full Text] [Related]
7. Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension.
Morris NR; Seale H; Harris J; Hall K; Lin AC; Kermeen F
Respirology; 2017 Jan; 22(1):165-171. PubMed ID: 27530086
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of exercise capacity in pulmonary arterial hypertension].
Demir R; Küçükoğlu MS
Turk Kardiyol Dern Ars; 2010 Dec; 38(8):580-8. PubMed ID: 21248462
[TBL] [Abstract][Full Text] [Related]
9. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension.
Huang J; Mehta S; Mura M
Respiration; 2015; 89(5):365-73. PubMed ID: 25791910
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
[TBL] [Abstract][Full Text] [Related]
11. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
[TBL] [Abstract][Full Text] [Related]
12. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.
Miyamoto S; Nagaya N; Satoh T; Kyotani S; Sakamaki F; Fujita M; Nakanishi N; Miyatake K
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):487-92. PubMed ID: 10673190
[TBL] [Abstract][Full Text] [Related]
14. Treatment goals of pulmonary hypertension.
McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
[TBL] [Abstract][Full Text] [Related]
15. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
[TBL] [Abstract][Full Text] [Related]
16. The role of exercise testing in the management of pulmonary arterial hypertension.
Oudiz RJ
Semin Respir Crit Care Med; 2005 Aug; 26(4):379-84. PubMed ID: 16121314
[TBL] [Abstract][Full Text] [Related]
17. Ambrisentan therapy for pulmonary arterial hypertension.
Galié N; Badesch D; Oudiz R; Simonneau G; McGoon MD; Keogh AM; Frost AE; Zwicke D; Naeije R; Shapiro S; Olschewski H; Rubin LJ
J Am Coll Cardiol; 2005 Aug; 46(3):529-35. PubMed ID: 16053970
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
Studer SM; Gilkin RJ
Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
[TBL] [Abstract][Full Text] [Related]
19. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.
Farber HW; Miller DP; McGoon MD; Frost AE; Benton WW; Benza RL
J Heart Lung Transplant; 2015 Mar; 34(3):362-8. PubMed ID: 25312386
[TBL] [Abstract][Full Text] [Related]
20. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
